Meeting Banner
Abstract #3506

Sampling Duration in DCE-MRI: in vivo Comparison Using Data Acquired Within a Clinical Phase I Study

Martin Buechert1, Henrik Gille2, Jan Kuhlmann3, Klaus Mross4

1MRDAC Magnetic Resonance Development and Application Center, University Medical Center Freiburg, Freiburg, Germany; 2Pieris AG, Freising, Germany; 3University Medical Center, Freiburg, Germany; 4Klinik fr Tumorbiologie, Freiburg, Germany

For assessing treatment response DCE-MRI is a valuable tool. Parameters calculated using pharmacokinetic modeling may depend on the sampling duration which equals the number of sampled data points for equally distributed sampling. This was previously investigated by computer simulations but there is limited verification of these findings using real in vivo patient data. This dependency on sampling duration of the Ktrans, Ve and the fit accuracy were investigated using patient data with a long sampling duration in comparison to an artificial shortened sub set of these data. Results were in agreement with the published simulations.

Keywords

acquisition additional agreement although always analyses analytic application appropriate assessing automatically breathing built cancer carried clinical cohort compartment computer concentration conditions consists constant contrast core coronal correlation covering curve curves custom decrease decreased defined dependency dependent describes developed development driven duration durations dynamic enhanced enough equal equals examinations example expression extended fact findings fitting free function functional in vivo independent inhomogeneous initial inversion investigated larger length lesion lesions like limited liver long mainly martin matrix medical metastasis minimize minutes model mostly movement novel observations oriented package part patient patients percentage permeability phys physiological possibly previously processing product protocol published quantification quantitative reach real received recovery required residual respectively response rise routine sampled sampling semi separate sets several significance simulation simulations since slice smaller software spanning statistical steps studies subgroup subset support surface target tendency therapeutics took tool tracked transfer treatment typical uniform valuable verification view whole